Form 4: Salesforce Executive R. David Schmaier Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


R. David Schmaier, President & Chief Product Officer of Salesforce, sold 1,785 shares of common stock at $280 per share on October 2, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On October 2, 2024, R. David Schmaier, the President & Chief Product Officer of Salesforce, sold 1,785 shares of Salesforce common stock.
  • The sale was executed at a price of $280 per share.
  • The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 28, 2024.
  • Following the transaction, Schmaier directly owns 19,396 shares of Salesforce common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine transaction.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. They can be driven by various factors, including personal financial planning and diversification. The use of 10b5-1 trading plans allows executives to sell shares at predetermined times and prices, avoiding concerns about insider trading.

Comparison to Industry Standards

  • Executive stock sales are a routine part of compensation and wealth management at companies like Salesforce, similar to practices at other large tech firms such as Microsoft, Apple, and Amazon.
  • Rule 10b5-1 trading plans are widely used by executives to schedule stock sales in advance, mitigating the risk of insider trading allegations, a practice common across the S&P 500.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply, but the effect is likely minimal given the relatively small number of shares sold.

Key Dates

DateDescription
June 28, 2024Date the reporting person adopted a Rule 10b5-1 trading plan
October 02, 2024Date of the transaction (stock sale)
October 03, 2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.